International Trade
April 17, 2013
|
February 27, 2013
|
July 19, 2012
|
June 19, 2012
|
Letters, Testimony & Comments
June 3 2013
BIO appreciates the opportunity to respond to the Request for Comments issued by the U.S. Trade Representative on objectives to be pursued in the negotiation of a Transatlantic Trade and Investment Partnership (TTIP) agreement.
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has developed and commercialized more than 300 biotechnology drugs and diagnostics and there are over 400 products in the pipeline.
January 18 2013
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments in response to the Controller General of Patents Designs and Trademarks in India on the "Draft Guidelines for Examination of Biotechnology Applications" hereafter referred to as "Draft Guidelines", or "Guidelines".
November 28 2012
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has reviewed the Guidelines and has identified specific questions, and areas for improvement.
November 8 2012
(BIO) is grateful for the opportunity to provide comments on India’s Draft National IPR Strategy, hereafter referred to as "Draft Strategy".
Want to learn more about the biotech industry?
Business Solutions Sponsor
